Bio-Rad Laboratories (BIO)

Bio-Rad Laboratories (BIO) Financial Statements


Bio-Rad Laboratories Financial Overview

Bio-Rad Laboratories's market cap is currently ―. The company's EPS TTM is $-121.431; its P/E ratio is -3.84; Bio-Rad Laboratories is scheduled to report earnings on April 27, 2023, and the estimated EPS forecast is $3.81. See an overview of income statement, balance sheet, and cash flow financials.
Dec 22Sep 22Jun 22Mar 22Dec 21
Income Statement-
Total Revenue$ 730.29M$ 680.80M$ 691.10M$ 700.06M$ 732.77M
Gross Profit$ 394.00M$ 373.79M$ 395.98M$ 403.56M$ 401.00M
EBIT$ 1.11B$ -197.50M$ -1.21B$ -4.37B$ -2.04B
EBITDA$ 1.15B$ -164.81M$ -1.18B$ -4.33B$ -2.00B
Net Income Common Stockholders$ 833.49M$ -164.23M$ -927.18M$ -3.37B$ -1.57B
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 1.79B$ 1.85B$ 1.97B$ 2.07B$ 869.92M
Total Assets$ 13.50B$ 12.06B$ 12.68B$ 14.37B$ 17.78B
Total Debt$ 1.39B$ 1.38B$ 1.39B$ 1.40B$ 223.38M
Net Debt$ -402.56M$ -471.17M$ -576.00M$ -669.76M$ -646.54M
Total Liabilities$ 3.89B$ 3.60B$ 3.76B$ 4.19B$ 4.11B
Stockholders Equity$ 9.62B$ 8.45B$ 8.92B$ 10.18B$ 13.67B
Cash Flow-
Free Cash Flow$ 43.49M$ -16.55M$ 35.94M$ 17.42M$ 114.68M
Operating Cash Flow$ 90.42M$ 7.51M$ 50.20M$ 46.31M$ 157.92M
Investing Cash Flow$ -69.31M$ -84.91M$ -141.41M$ -911.96M$ -554.48M
Financing Cash Flow$ -86.62M$ -8.77M$ -121.33M$ 1.19B$ 4.63M
Currency in USD

Bio-Rad Laboratories Earnings and Revenue History

Bio-Rad Laboratories Debt to Assets

Bio-Rad Laboratories Cash Flow

Bio-Rad Laboratories Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis